Status:
COMPLETED
Efficacy and Safety of Angelica Gigas N. Extract on Improvement of Hyperglycemia
Lead Sponsor:
Chonbuk National University Hospital
Conditions:
Hyperglycemia
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
This study was conducted to investigate the effects of daily supplementation of Angelica gigas N. extract on improvement of Hyperglycemia .
Detailed Description
This study was a 8 weeks, randomized, double-blind, placebo-controlled 2×2 cross-over design human trial. Twenty subjects were randomly divided into Angelica gigas N. extract or a placebo group. Fasti...
Eligibility Criteria
Inclusion
- Age 20-80 years with fasting glucose 100-125 mg/dL or 2 hour postprandial glucose 140-199 mg/dl
Exclusion
- Weight less than 48 kg or weight decreased by more than 10% within past 3 months
- Hypoglycemic agent, Obesity medicine, Lipid lowering agent within past 6 months or Blood sugar, Obesity and Lipid improvement functional foods within past 2 weeks
- Treated with corticosteroid within past 4 weeks
- Severe cardiovascular disease(Mvocardial infarction, Stroke, etc)
- Renal disease(Heredity hyperlipidemia, Acute/Chronic renal failure, Nephrotic syndrome, etc)
- Rheumatoid arthritis, Autoimmune disease
- Cancer, Respiratory organ disease(Asthma, Chronic obstructive pulmonary disease)
- Allergic or hypersensitive to any of the ingredients in the test products
- History of disease that could interfere with the test products or impede their absorption
- Under antipsychotic drugs therapy within past 2 months
- History of alcohol or substance abuse
- Participation in any other clinical trials within past 2 months
- Laboratory test by show the following results
- aspartate aminotransferase, alanine aminotransferase \> Reference range upper limit treble
- Serum Creatinine \> 2.0 mg/dl
- Pregnancy or breast feeding
- Not Contraception(except: Surgery for female infertility)
Key Trial Info
Start Date :
February 9 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 7 2017
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03258229
Start Date
February 9 2017
End Date
December 7 2017
Last Update
August 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Trial Center for Functional Foods; Chonbuk National University Hospital
Jeonju, Jeollabuk-do, South Korea, 560-822